Cargando…
Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects
The aim of this study was to evaluate the efficacy and toxicity of low-dose methotrexate with folinic acid rescue in a large series of consecutively treated patients with low-risk persistent gestational trophoblastic disease. Between January 1987 and December 2000, 250 patients were treated with int...
Autores principales: | Khan, F, Everard, J, Ahmed, S, Coleman, R E, Aitken, M, Hancock, B W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395266/ https://www.ncbi.nlm.nih.gov/pubmed/14676794 http://dx.doi.org/10.1038/sj.bjc.6601422 |
Ejemplares similares
-
Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate.
por: Gillespie, A. M., et al.
Publicado: (1997) -
Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis
por: Sharma, S, et al.
Publicado: (1999) -
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000) -
Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease
por: Walkington, L, et al.
Publicado: (2011) -
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022)